Task B28: Efficacy Studies for Therapeutics Development

NIH RePORTER · NIH · N01 · $198,565 · view on reporter.nih.gov ↗

Abstract

This task provides for lead identification, development, chemistry and synthesis services under the NIAID Preclinical Services for the Development of Interventional Agents Program.

Key facts

NIH application ID: 10703289
Project number: 272201800001I-0-759302200009-1
Recipient: SRI INTERNATIONAL
Principal Investigator: LEYI GONG
Activity code: N01
Funding institute: NIH
Fiscal year: 2022
Award amount: $198,565
Award type: —
Project period: 2022-09-15 → 2023-03-14